InterventionsHuman trial

Efficacy and Safety of BGM0504 in Chinese Patients with Type 2 Diabetes—A Multicenter, Randomized, Double-Blind, Placebo-Controlled and Semaglutide Positive-Controlled Phase 2 Trial

ADA Scientific Sessions 2025 Abstract

The paper

Jiandong Yuan, Yangqing Huang, Haifeng Ding,
Show 5 more authorsDaosheng Xie, Xiaohui Jiang, Xuemei Yuan, Zhao Cao, Ping Jin,
Linong Ji

Suzhou

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Oral 303-OR

doi.org/10.2337/db25-303-or

Related